Analysis Of Income And Expense [Abstract]

Sopharma Trading AD - Filing #6022492

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Finance income (cost)
4,383,000.000 BGN
3,820,000.000 BGN
Other operating income (expense)
8,223,000.000 BGN
9,192,000.000 BGN
Expenses by nature [abstract]
Raw materials and consumables used
9,042,000.000 BGN
6,863,000.000 BGN
Services expense
16,039,000.000 BGN
13,614,000.000 BGN
Classes of employee benefits expense [abstract]
Employee benefits expense
80,841,000.000 BGN
57,303,000.000 BGN
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
28,554,000.000 BGN
20,040,000.000 BGN
Other expenses, by nature
10,183,000.000 BGN
4,808,000.000 BGN
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss
11,000.000 BGN
- BGN
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- BGN
- BGN
- BGN
8,000.000 BGN
87,000.000 BGN
7,962,000.000 BGN
8,041,000.000 BGN
11,408,000.000 BGN
- BGN
11,417,000.000 BGN
9,000.000 BGN
- BGN
- BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.